Loading paragraph...
Today's Most Actively Traded Stocks
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| IBIT | iShares Bitcoin Trust | $36.10 | -$5.47 | -13.16% | 284.4M | - | $35.30$71.82 |
| TQQQ | ProShares Trust - ProShares UltraPro Qqq | $47.64 | -$2.12 | -4.26% | 158.7M | - | $17.50$60.69 |
| ETHA | iShares Ethereum Trust - iShares Ethereum Trust ETF | $14.06 | -$2.28 | -13.95% | 110.8M | - | $10.99$36.80 |
| TSLL | Direxion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares | $14.50 | -$0.67 | -4.42% | 89.7M | - | $6.29$23.74 |
| GOOGL | Alphabet | $331.25 | -$1.79 | -0.54% | 88.2M | $4.0T | $140.53$349.00 |
| SOFI | SoFi Technologies | $19.46 | -$1.29 | -6.22% | 87.5M | $26B | $8.60$32.73 |
| SQQQ | ProShares Trust - ProShares UltraPro Short Qqq | $74.58 | $3.09 | 4.32% | 79.6M | - | $61.72$289.00 |
| HIMS | Hims & Hers Health | $23.48 | -$0.92 | -3.77% | 71.3M | $5.6B | $22.95$72.98 |
| MSFT | Microsoft | $393.67 | -$20.52 | -4.95% | 66.3M | $2.9T | $344.79$555.45 |
| CFLT | Confluent | $30.36 | $0.03 | 0.08% | 6.5M | $11B | $15.64$37.90 |
| NVDA | Nvidia | $171.83 | -$2.36 | -1.35% | 6.4M | $4.2T | $86.62$212.19 |
| AMZN | Amazon | $222.83 | -$10.17 | -4.36% | 5.2M | $2.4T | $161.38$258.60 |
| INTC | Intel | $48.21 | -$0.39 | -0.80% | 4.4M | $241B | $17.67$54.60 |
| PLTR | Palantir Technologies | $129.95 | -$9.59 | -6.87% | 4.3M | $333B | $66.12$207.52 |
| QQQ | Invesco QQQ Trust | $597.28 | -$8.47 | -1.40% | 3.9M | - | $402.39$637.01 |
| KVUE | Kenvue | $18.05 | $0.04 | 0.19% | 3.5M | $35B | $14.02$25.17 |
| ONDS | Ondas | $8.46 | -$1.23 | -12.65% | 3.2M | $3.6B | $0.57$15.28 |
| PFE | Pfizer | $26.50 | -$0.28 | -1.05% | 3M | $152B | $20.92$27.69 |
| TSLA | Tesla | $396.97 | -$9.04 | -2.23% | 2.9M | $1.3T | $214.25$498.83 |
| OWL | Blue Owl Capital | $11.61 | -$0.46 | -3.77% | 2.8M | $7.7B | $10.88$24.94 |
| F | Ford Motor Company | $13.72 | -$0.10 | -0.72% | 2.3M | $55B | $8.44$14.50 |
Related Articles
Featured Article
Alphabet Just Delivered Great News for Nvidia Stock Investors
Jeremy Bowman|Feb 5, 2026
Alphabet is doubling its capex spend to $175 billion-$185 billion this year.

Down 28% From Its Highs, Is Microsoft Stock a Buy?
Daniel Sparks|Feb 5, 2026
After a rough start to 2026, is the software giant's stock attractive as it invests heavily in AI?

Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.
Reuben Gregg Brewer|Feb 5, 2026
There's another fight brewing around GLP-1 drugs -- this time on the delivery side.

Wall Street Sees Artificial Intelligence (AI) as a Decade-Long Opportunity. This Stock Is an Early Winner.
Harsh Chauhan|Feb 5, 2026
Customers are rushing to adopt this company's offerings to leverage the productivity gains AI delivers.

This AI Giant May Advance 46%, According to Wall Street. And Right Now, It's Dirt Cheap.
Adria Cimino|Feb 5, 2026
The stock today trades at its lowest valuation in at least three years.

1 Important Number Nvidia Investors Should Watch on Feb. 25 -- and Nobody Is Talking About It
Anthony Di Pizio|Feb 5, 2026
There might be a key risk hiding in Nvidia's upcoming 10-K filing with the Securities and Exchange Commission.

Amazon's Cloud Business Is Accelerating. Time to Buy the Stock?
Daniel Sparks|Feb 5, 2026
Does the stock really deserve the beating it is taking following its earnings report?

Hims & Hers Takes On Novo Nordisk: What We Know Right Now
Travis Hoium|Feb 5, 2026
Hims & Hers fell on fear that Novo Nordisk would take action against the company's new oral GLP-1, but there's more to the story.
2 "Magnificent Seven" Stocks to Buy at a Discount
Patrick Sanders|Feb 5, 2026
Both of these stocks are down more than 10% from their all-time highs.

One Analyst Thinks Tesla's Robotaxi Revenue Could Soar to $250 Billion by 2035, But Here Are 2 Things Investors Need to Know
Bram Berkowitz|Feb 5, 2026
Tesla's robotaxi business has immense potential, but Tesla also trades at a high valuation.
